Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Andrologia ; 50(8): e13071, 2018 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-29987899

RESUMEN

The main objective of this study was to evaluate the effects of a micronutrient supplementation (MS) combined with avanafil on sperm function. Oligoasthenospermic men (n = 217) were treated daily for 90 days with either an MS (45 men, Group A), l-carnitine (44 men, Group B), MS plus avanafil (43 men, Group C) or avanafil (43 men, Group D); another group of 42 men with oligoasthenospermia (Group E) received no treatment. Sperm parameters were evaluated before and after the end of treatment in each Group A, B, C and D respectively. The same sperm parameters were measured in each participant of Group E before and at the 90-day experimental period. Within Groups A, C or D, the total percentage of motile spermatozoa, the hypoosmotic swelling test (HOST) result and the percentage of hyperactivated spermatozoa after incubation under conditions known to induce sperm capacitation were significantly greater after MS or MS plus avanafil treatment, or avanafil treatment than before the respective treatment. We suggest that MS or MS plus avanafil combined administration or avanafil alone improves sperm membrane permeability with an overall result improvement in sperm motility, outcome of HOST and increase in the percentage of hyperactivated spermatozoa.


Asunto(s)
Infertilidad Masculina/tratamiento farmacológico , Micronutrientes/uso terapéutico , Inhibidores de Fosfodiesterasa 5/uso terapéutico , Pirimidinas/uso terapéutico , Espermatozoides/efectos de los fármacos , Suplementos Dietéticos , Femenino , Hormona Folículo Estimulante/sangre , Humanos , Infertilidad Masculina/sangre , Hormona Luteinizante/sangre , Masculino , Inhibidores de Fosfodiesterasa 5/farmacología , Embarazo , Índice de Embarazo , Pirimidinas/farmacología , Semen/metabolismo , Motilidad Espermática/efectos de los fármacos , Testosterona/sangre , Zinc/metabolismo
2.
Asian J Androl ; 19(6): 639-646, 2017.
Artículo en Inglés | MEDLINE | ID: mdl-27748317

RESUMEN

Diabetes mellitus significantly affects the male reproduction and sexual function. In the present study, we investigated the diabetes-induced dysfunction of seminal vesicles (SVs) in the diabetes-rat model and the role of antioxidants. Streptozotocin-induced diabetes after 4 weeks caused smaller size of the organs, hypercontractility, histological abnormalities, increased concentrations of malondialdehyde in the serum and tissue, overexpression of oxidative stress markers, and cleaved caspase-3 as identified by immunohistochemistry in the SVs. In addition, diabetes resulted in deceased levels of serum testosterone and no newborns after the mating studies. Antioxidants significantly normalized all the above parameters, except for the severely decreased serum testosterone levels and the negative outcome of the mating studies. The present study gives evidence for the important role of diabetes-induced oxidative stress in the function and structure of these androgen-dependent organs. Antioxidants may be a promising supplementary therapy for diabetic male patients to alleviate ejaculatory disorders but alone is not efficient treatment for the mitigation of infertility.


Asunto(s)
Antioxidantes/farmacología , Diabetes Mellitus Experimental/metabolismo , Fertilidad/efectos de los fármacos , Depuradores de Radicales Libres/farmacología , Estrés Oxidativo/efectos de los fármacos , Animales , Antipirina/análogos & derivados , Antipirina/farmacología , Caspasa 3/metabolismo , Edaravona , Peroxidación de Lípido/efectos de los fármacos , Masculino , Malondialdehído/metabolismo , Ratas , Ratas Wistar , Vesículas Seminales/efectos de los fármacos , Vesículas Seminales/metabolismo , Taurina/farmacología , Testosterona/sangre
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA